![]()
medlinkImmunotherapy/medlink, known for its effectiveness in cancers with mismatch repair deficiency, shows potential benefits for patients with medlinkendometrial/medlink and medlinkcolon cancer/medlink as well. (!--ref1--)
Endometrial and colon cancer patients often have high rates of mismatch repair deficiency -- a genetic state where errors in DNA occur due to a lack of certain repair proteins. This state impairs DNA's ability to repair itself and can lead to many types of cancer....